Yair Green,
Attorney at Law, Yeshaya Horowitz Association
David Watumull,
President and CEO, Cardax Pharmaceuticals Inc.
Moderator:
Martha Amram, CEO, GreenNow USA; Senior Fellow, Milken Institute
Yair Green (left) and David Watumull (right) discuss how to spur investment that could lead to new medical breakthroughs.
Funding for biomedical research and development has fallen off in recent years. Large pharmaceutical companies have watched their stock values drop and their business models crumble, and they're shying away from risky early-stage drug discovery and development. Research and development output, as measured by FDA applications for approval to initiate clinical trials and market new drugs, has plummeted. The shortage of investment capital remains acute; it's being felt from drug and device discovery all the way through clinical trials. Can financial technology help? How can we bridge the gap in medical innovation funding? Which partnerships can be crafted quickly to weave together incentives, ideas and financing to drive the next generation of health-care breakthroughs?
Global Conference 2013
Former Prime Minister Tony Blair, philanthropist Bill Gates and Strive Masiyiwa of Econet Wireless discuss advancing prosperity in Africa.
